VSVS🃏All Jynx cards
Ask about Clair's Jynx
Clair's Jynx #47 Pokémon card from Japanese VS
Japanese

Clair's Jynx 47/142

VS· Language: Japanese

👁 Watch📊 Add to portfolioFree — no card required to register.
Find this card on eBay

Affiliate link · we may earn commission

Clair's Jynx #47 from Japanese VS currently trades at $26.99 raw, with PSA 10 copies reaching $400.00 — a 14.8x grade premium.
Current Prices (USD)
Ungraded
$26.99
PSA 7
$30.50
PSA 8
$43.50
PSA 9
$58.45
PSA 10
$400.00
ACE 10
BGS 10 Black
$2,600.00
CGC 10 Pristine
$90.00
Compare on eBay

Affiliate link · we may earn commission

Raw Price Trend
7d
30d
90d
180d
+88.3%
1y
+104.6%
2y
+208.5%
5y

Quick price facts

Clair's Jynx 47/142 from VS has a current raw market value of $26.99.

Current raw value
$26.99
PSA 9 value
$58.45
PSA 10 value
$400
PSA 10 premium vs raw
14.8× raw
View all cards from VS
Collector Intel
14.8x
Raw → PSA 10
High-risk grade
2.2x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

$27
Buy Raw
~$25
Grading Fee
PSA Standard
$400
PSA 10 Value
+$348
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$582.2x raw
PSA 10$40014.8x raw

Frequently asked questions

How much is Clair's Jynx #47 from Japanese VS worth?+
Clair's Jynx #47 from Japanese VS is currently worth Raw: $26.99, PSA 9: $58.45, PSA 10: $400 based on recent sold listings. Prices update daily from real eBay sales.
Is Clair's Jynx #47 worth grading?+
The PSA 10 price of $400 is 14.8× the raw price of $26.99. After a ~$25 grading fee, a PSA 10 result would net approximately $373 — assuming the card grades a 10.
Where do PokePrices Clair's Jynx #47 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.